Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,137 | 652 | 99.8% |
| Education | $17.18 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $1,345 | 89 | $0 (2024) |
| Novo Nordisk Inc | $1,289 | 94 | $0 (2024) |
| Amgen Inc. | $962.25 | 48 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $826.24 | 49 | $0 (2024) |
| Lilly USA, LLC | $742.58 | 50 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $678.82 | 52 | $0 (2023) |
| ABBVIE INC. | $458.43 | 42 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $337.11 | 14 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $301.94 | 17 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $289.06 | 18 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,900 | 99 | AstraZeneca Pharmaceuticals LP ($388.44) |
| 2023 | $1,507 | 88 | PFIZER INC. ($232.78) |
| 2022 | $1,575 | 90 | Novo Nordisk Inc ($390.95) |
| 2021 | $1,316 | 91 | Amgen Inc. ($176.11) |
| 2020 | $904.01 | 51 | Teva Pharmaceuticals USA, Inc. ($145.44) |
| 2019 | $1,210 | 81 | PFIZER INC. ($278.30) |
| 2018 | $1,006 | 83 | Novo Nordisk Inc ($172.41) |
| 2017 | $736.48 | 71 | Lilly USA, LLC ($126.15) |
All Payment Transactions
654 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/13/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Respiratory | ||||||
| 12/09/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: Neurology | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Respiratory | ||||||
| 12/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: PAIN | ||||||
| 12/02/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Cardiology | ||||||
| 11/25/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: Obesity | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: RESPIRATORY | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $32.75 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/12/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Obesity | ||||||
| 11/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $9.32 | General |
| Category: Inflammation | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Respiratory | ||||||
| 10/31/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Inflammation | ||||||
| 10/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: DIABETES | ||||||
| 10/28/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Gastroenterology | ||||||
| 10/21/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $6.89 | General |
| Category: Inflammation | ||||||
| 10/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.07 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Respiratory | ||||||
| 10/15/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.93 | General |
| Category: Cardiovascular | ||||||
| 10/14/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: PSYCHIATRY | ||||||
| 10/10/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: PSYCHIATRY | ||||||
| 10/08/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: Inflammation | ||||||
| 10/06/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 2,014 | 3,167 | $480,745 | $211,331 |
| 2022 | 22 | 2,430 | 4,529 | $574,325 | $243,852 |
| 2021 | 26 | 2,421 | 4,803 | $686,568 | $295,722 |
| 2020 | 25 | 1,783 | 3,218 | $513,957 | $207,200 |
All Medicare Procedures & Services
99 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 385 | 772 | $163,664 | $67,875 | 41.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 277 | 277 | $62,325 | $33,935 | 54.4% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 52 | 237 | $42,660 | $18,921 | 44.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 65 | 283 | $40,752 | $17,197 | 42.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 65 | 94 | $37,882 | $12,471 | 32.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 64 | 130 | $27,040 | $11,860 | 43.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 81 | 112 | $16,352 | $7,372 | 45.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 47 | 65 | $13,780 | $5,712 | 41.5% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 76 | 76 | $6,840 | $5,686 | 83.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 41 | 41 | $13,243 | $4,736 | 35.8% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 36 | 38 | $9,766 | $3,878 | 39.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 23 | 23 | $7,659 | $3,616 | 47.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 40 | 50 | $7,250 | $3,053 | 42.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 11 | 11 | $5,214 | $2,296 | 44.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 20 | 23 | $6,325 | $2,274 | 35.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 75 | 75 | $2,100 | $2,058 | 98.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 12 | 12 | $3,800 | $1,890 | 49.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 108 | 108 | $4,860 | $1,861 | 38.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 210 | 251 | $1,915 | $1,679 | 87.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 227 | 310 | $2,170 | $1,041 | 48.0% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 11 | 19 | $2,603 | $1,032 | 39.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 37 | 38 | $1,254 | $381.50 | 30.4% |
| 69209 | Removal of impacted ear wax by washing | Office | 2023 | 11 | 17 | $459.00 | $245.96 | 53.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 19 | $532.00 | $201.40 | 37.9% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 11 | 16 | $160.00 | $51.45 | 32.2% |
About Dr. Emad Daher, MD
Dr. Emad Daher, MD is a Internal Medicine healthcare provider based in Port Huron, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1265415285.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Emad Daher, MD has received a total of $10,154 in payments from pharmaceutical and medical device companies, with $1,900 received in 2024. These payments were reported across 654 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($10,137).
As a Medicare-enrolled provider, Daher has provided services to 8,648 Medicare beneficiaries, totaling 15,717 services with total Medicare billing of $958,105. Data is available for 4 years (2020–2023), covering 99 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Port Huron, MI
- Active Since 11/23/2005
- Last Updated 02/12/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1265415285
Products in Payments
- XARELTO (Drug) $594.12
- ELIQUIS (Drug) $559.49
- Ozempic (Drug) $492.18
- FARXIGA (Drug) $438.92
- Repatha (Biological) $436.34
- MOUNJARO (Drug) $390.03
- Rybelsus (Drug) $334.93
- REXULTI (Drug) $303.02
- ENTRESTO (Drug) $268.81
- Otezla (Drug) $268.54
- JARDIANCE (Drug) $263.35
- VRAYLAR (Drug) $248.16
- Vascepa (Drug) $239.93
- Victoza (Drug) $215.95
- NURTEC ODT (Drug) $203.43
- COLOGUARD (Device) $191.41
- CHANTIX (Drug) $177.09
- TRADJENTA (Drug) $171.67
- TRULICITY (Drug) $169.37
- Kerendia (Drug) $164.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Port Huron
Charbal Bazo, Md, MD
Internal Medicine — Payments: $11,427
Riad Hajjar, M.d, M.D
Internal Medicine — Payments: $7,897
Dr. Gabriel Crawford, D.o, D.O
Internal Medicine — Payments: $7,443
Ali Haidar, M.d, M.D
Internal Medicine — Payments: $3,420
Ronaldo Balboa, M.d, M.D
Internal Medicine — Payments: $1,893
Anil Patel, Md, MD
Internal Medicine — Payments: $1,346